Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Lama-Diaz

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|May 23, 2024
Alternative translation initiation by ribosomal leaky scanning produces multiple isoforms of the Pif1 helicaseTomas Lama-Diaz, Miguel G Blanco
Methods in Molecular Biology (Clifton, N.J.)|August 26, 2020
Holliday Junction ResolutionRaquel Carreira, F Javier Aguado, Tomas Lama-Diaz, et al.
Nucleic Acids Research|June 4, 2024
Concurrent D-loop cleavage by Mus81 and Yen1 yields half-crossover precursorsRaquel Carreira, Tomas Lama-Diaz, Maria Crugeiras, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
SMARCAL1 is a candidate therapeutic target for ALT-positive tumorsAngelo Taglialatela, Jina Lee, Benura Azeroglu, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Mapping the genetic landscape of the DNA damage response with Cas12a-based combinatorial knockout screensSamuel B Hayward, Alina Vaitsiankova, Tomas Lama-Diaz, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|May 23, 2024
Alternative translation initiation by ribosomal leaky scanning produces multiple isoforms of the Pif1 helicaseTomas Lama-Diaz, Miguel G Blanco
Methods in Molecular Biology (Clifton, N.J.)|August 26, 2020
Holliday Junction ResolutionRaquel Carreira, F Javier Aguado, Tomas Lama-Diaz, et al.
Nucleic Acids Research|June 4, 2024
Concurrent D-loop cleavage by Mus81 and Yen1 yields half-crossover precursorsRaquel Carreira, Tomas Lama-Diaz, Maria Crugeiras, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
SMARCAL1 is a candidate therapeutic target for ALT-positive tumorsAngelo Taglialatela, Jina Lee, Benura Azeroglu, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Mapping the genetic landscape of the DNA damage response with Cas12a-based combinatorial knockout screensSamuel B Hayward, Alina Vaitsiankova, Tomas Lama-Diaz, et al.
Pageof 1